Penwest Second Quarter 2009 Financial Results Conference Call
July 29, 2009 16:15 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., July 29, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Friday, August 7, at 11:00 a.m. EDT to review its financial results for...
Penwest Announces Results of Phase Ib Trial of A0001
July 16, 2009 08:00 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., July 16, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced the results of its Phase Ib clinical trial of A0001, a compound the Company is developing...
Penwest Announces That the Results of Its Annual Meeting Have Been Certified
June 24, 2009 16:30 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., June 24, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that IVS Associates, Inc., the independent inspector of election for the Company's Annual...
Penwest Enters Into Third Research and Development Agreement With Otsuka Pharmaceutical
June 17, 2009 08:00 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., June 17, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed its third research and development agreement with Otsuka Pharmaceutical...
Penwest Announces Preliminary Vote Count At Annual Meeting
June 10, 2009 13:41 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., June 10, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced the preliminary results of its Annual Meeting of Shareholders, which was held today.
Based...
Penwest Urges Shareholders to Vote the White Proxy Card Today and Reject Dissident Proposals and Nominees At Wednesday's Annual Meeting
June 09, 2009 10:00 ET
|
Penwest Pharmaceuticals Co.
Just Announced Licensing Agreement for Opana ER(r) Outside U.S.
is Tangible Evidence That Penwest is Successfully Executing Its
Strategy to Build Shareholder Value
...
Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
June 09, 2009 07:30 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., CHADDS FORD, Pa., and ALISO VIEJO, Calif., June 9, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO), Endo Pharmaceuticals (Nasdaq:ENDP) and Valeant Pharmaceuticals...
Leading Proxy Advisory Firms RiskMetrics Group and Glass Lewis Recommend Penwest Shareholders Vote Against All Three Dissident Proxy Proposals
June 01, 2009 16:47 ET
|
Penwest Pharmaceuticals Co.
Firms Unconvinced by Dissidents' Wind-Down Proposal
Penwest Urges Shareholders to Vote FOR Its Director Nominees and
AGAINST Dissidents' Proposals On the WHITE Proxy Card,...
Washington State Court Denies Dissidents' Request for Preliminary Injunction in Penwest Proxy Vote
May 22, 2009 16:12 ET
|
Penwest Pharmaceuticals Co.
Company Plans to Proceed with Voting for Two Director Seats at
June 10 Annual Meeting
Strongly Urges Shareholders to Vote Against Tang Capital and
...
Penwest Urges Shareholders to Reject Tang Capital and Perceptive's Wind Down Proposal
May 19, 2009 09:00 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., May 19, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today sent a letter to its shareholders in connection with the Company's annual meeting to be held on June...